n.beaulieu
Submits third-party assay reports on material purchased directly. Based in Zaragoza.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.02%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043227 | ARA-290 | SGN | SGN-2605-X9069 | PeptideMeter | 2026-Q2 | 98.38 | 7.21 | 95.6 | Buyer-sourced | 0 | PASS |
| AX-2026-042039 | Epitalon | HYB | HYB-2603-U7133 | Medutest | 2026-Q2 | 99.93 | 6.17 | 103.9 | Buyer-sourced | 0 | FAIL |
| AX-2025-020753 | Tirzepatide | SGN | SGN-2505-G9079 | Nordanalyt | 2025-Q4 | 99.02 | 5.06 | 89.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019323 | Semaglutide | AMB | AMB-2503-S5891 | Janoshik | 2025-Q3 | 99.41 | 5.52 | 94.5 | Buyer-sourced | 0 | PASS |
| AX-2025-020978 | PT-141 (Bremelanotide) | WXT | WXT-2507-R4042 | Medutest | 2025-Q3 | 98.65 | 4.38 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020483 | Liraglutide | KP | KP-2502-E5631 | VendorInvestigate | 2025-Q1 | 98.98 | 6.27 | 93.3 | Buyer-sourced | 0 | PASS |
| AX-2025-021025 | PT-141 (Bremelanotide) | WXT | WXT-2411-R3766 | Medutest | 2025-Q1 | 98.69 | 6.18 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004376 | L-Glutathione (reduced) | FGP | FGP-2405-E9260 | Janoshik | 2024-Q3 | 99.36 | 5.60 | 104.3 | Buyer-sourced | 0 | PASS |
| AX-2024-004891 | Gonadorelin | ERP | ERP-2406-C9933 | Janoshik | 2024-Q3 | 99.93 | 3.92 | 97.0 | Buyer-sourced | 0 | PASS |